Clinical observation on the safety and efficacy of umbilical cord mesenchymal stem cells in the treatment of bronchiolitis obliterans after allogeneic haematopoietic stem cell transplantation

References

• Aguilar, P. R., Michelson, A. P., & Isakow, W. (2016). Obliterative bronchiolitis. Transplantation, 100(2), 272–283. https://doi.org/10.1097/tp.0000000000000892
   PubMed Web of Science ®Google Scholar
• Ankrum, J. A., Ong, J. F., & Karp, J. M. (2014). Mesenchymal stem cells: Immune evasive, not immune privileged. Nature Biotechnology, 32(3), 252–260. https://doi.org/10.1038/nbt.2816
   PubMed Web of Science ®Google Scholar
• Astashchanka, A., Ryan, J., Lin, E., Nokes, B., Jamieson, C., Kligerman, S., Malhotra, A., Mandel, J., & Joshua, J. (2021). Pulmonary complications in hematopoietic stem cell transplant recipients—A clinician primer. Journal of Clinical Medicine, 10(15), 3227. https://doi.org/10.3390/jcm10153227
   PubMed Web of Science ®Google Scholar
• Ayas, M., Saber, W., Davies, S. M., Harris, R. E., Hale, G. A., Socie, G., LeRademacher, J., Thakar, M., Deeg, H. J. J., Al-Seraihy, A., Battiwalla, M., Camitta, B. M., Olsson, R., Bajwa, R. S., Bonfim, C. M., Pasquini, R., MacMillan, M. L., George, B., Copelan, E. A. … Gale, R. P. (2013). Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or Acute Leukemia. Journal of Clinical Oncology, 31(13), 1669–1676. https://doi.org/10.1200/jco.2012.45.9719
   PubMed Web of Science ®Google Scholar
• Bergeron, A., & Cheng, G. -S. (2017). Bronchiolitis obliterans syndrome and other late pulmonary complications after allogeneic hematopoietic stem cell transplantation. Clinics in Chest Medicine, 38(4), 607–621. https://doi.org/10.1016/j.ccm.2017.07.003
   PubMed Web of Science ®Google Scholar
• Bezler, N. S., Ilowite, M., London, W. B., Pei-Chi, K., Joffe, S., & Mack, J. W. (2022). Health literacy and clinical outcomes following hematopoietic stem-cell transplantation. JCO Oncology Practice, 18(6), e857–868. https://doi.org/10.1200/OP.21.00049
   PubMedGoogle Scholar
• Bondeelle, L., & Bergeron, A. (2019). Managing pulmonary complications in allogeneic hematopoietic stem cell transplantation. Expert Review of Respiratory Medicine, 13(1), 105–119. https://doi.org/10.1080/17476348.2019.1557049
   PubMed Web of Science ®Google Scholar
• Chamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007). Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells, 25(11), 2739–2749. https://doi.org/10.1634/stemcells.2007-0197
   PubMed Web of Science ®Google Scholar
• Copelan, E. A. (2006). Hematopoietic stem-cell transplantation. The New England Journal of Medicine, 354(17), 1813–1826. https://doi.org/10.1056/nejmra052638
   PubMed Web of Science ®Google Scholar
• Diab, M., ZazaDityafawi, J., & Soubani, A. O. (2016). Major pulmonary complications after hematopoietic stem cell transplant. Experimental and Clinical Transplantation, 14(3), 259–270. https://doi.org/10.6002/ect.2015.0275
   PubMed Web of Science ®Google Scholar
• Ding, D. -C., Shyu, W. -C., & Lin, S. -Z. (2011). Mesenchymal stem cells. Cell Transplantation, 20(1), 5–14. https://doi.org/10.3727/096368910x
   PubMed Web of Science ®Google Scholar
• Fujii, N., Nakase, K., Asakura, S., Matsuo, K., Nawa, Y., Sunami, K., Nishimori, H., Matsuoka, K. -I., Kondo, E., Maeda, Y., Shinagawa, K., Hara, M., & Tanimoto, M. (2014). Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation: A 10-year experience of the Okayama BMT group. International Journal of Hematology, 99(5), 644–651. https://doi.org/10.1007/s12185-014-1556-4
   PubMed Web of Science ®Google Scholar
• Galipeau, J., & Sensébé, L. (2018). Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities. Cell Stem Cell, 22(6), 824–833. https://doi.org/10.1016/j.stem.2018.05.004
   PubMed Web of Science ®Google Scholar
• Grønningsæter, I. S., Tsykunova, G., Lilleeng, K., Ahmed, A. B., Bruserud, Ø., & Reikvam, H. (2017). Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment. Expert Review of Clinical Immunology, 13(6), 553–569. https://doi.org/10.1080/1744666x.2017.1279053
   PubMed Web of Science ®Google Scholar
• Hakim, A., Cooke, K. R., Pavletic, S. Z., Khalid, M., Williams, K. M., & Hashmi, S. K. (2019). Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally. Bone Marrow Transplantation, 54(3), 383–392. https://doi.org/10.1038/s41409-018-0266-6
   PubMed Web of Science ®Google Scholar
• Hamilton, B. K., & Copelan, E. A. (2012). Concise review: The role of hematopoietic stem cell transplantation in the treatment of Acute Myeloid Leukemia. Stem Cells, 30(8), 1581–1586. https://doi.org/10.1002/stem.1140
   PubMed Web of Science ®Google Scholar
• Haniffa, M. A., Collin, M. P., Buckley, C. D., & Dazzi, F. (2008). Mesenchymal stem cells: The fibroblasts’ new clothes? Haematologica, 94(2), 258–263. https://doi.org/10.3324/haematol.13699
   PubMed Web of Science ®Google Scholar
• Hostettler, K. E., Halter, J. P., Gerull, S., Lardinois, D., Savic, S., Roth, M., & Tamm, M. (2014). Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation. The European Respiratory Journal, 43(1), 221–232. https://doi.org/10.1183/09031936.00199312
   PubMed Web of Science ®Google Scholar
• Iyer, M., Shreshtha, I., Baradia, H., & Chattopadhyay, S. (2022). Challenges and opportunities of using immobilized lipase as biosensor. Biotechnology & Genetic Engineering Reviews, 38(1), 87–110. https://doi.org/10.1080/02648725.2022.2050499
   PubMed Web of Science ®Google Scholar
• Migdady, Y., Pang, Y., Kalsi, S. S., Childs, R., & Arai, S. (2022). Post–hematopoietic stem cell transplantation immune-mediated anemia: A literature review and novel therapeutics. Blood Advances, 6(8), 2707–2721. https://doi.org/10.1182/bloodadvances.2021006279
   PubMed Web of Science ®Google Scholar
• Mo, X. (2013). Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation. Chinese Medical Journal, 126(13). https://pubmed.ncbi.nlm.nih.gov/23823823/
   Web of Science ®Google Scholar
• Mura, M., & Juvet, S. (2019). Bronchiolitis obliterans syndrome as manifestation of lung GVHD: Not the only one. Respirology (Carlton, Vic), 24(7), 702. https://doi.org/10.1111/resp.13567
   PubMed Web of Science ®Google Scholar
• Nakaseko, C., Ozawa, S., Sakaida, E., Sakai, M., Kanda, Y., Oshima, K., Kurokawa, M., Takahashi, S., Ooi, J., Shimizu, T., Yokota, A., Yoshiba, F., Fujimaki, K., Kanamori, H., Sakai, R., Saitoh, T., Sakura, T., Maruta, A., Sakamaki, H., & Okamoto, S. (2011). Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation. International Journal of Hematology, 93(3), 375–382. https://doi.org/10.1007/s12185-011-0809-8
   PubMed Web of Science ®Google Scholar
• Noguchi, M., Chen-Yoshikawa, T. F., Arai, Y., Kondo, T., Ohsumi, A., Nakajima, D., Hamaji, M., Takita, J., Takaori-Kondo, A., & Date, H. (2022). Expanded indications for lung transplantation for pulmonary complications after hematopoietic stem cell transplantation. The Journal of Thoracic and Cardiovascular Surgery, 163(4), 1549–1557.e4. https://doi.org/10.1016/j.jtcvs.2020.10.065
   PubMed Web of Science ®Google Scholar
• Oikonomopoulou, C., Paisiou, A., Ioannidou, E. -D., Komitopoulou, A., Kaisari, A., Zisaki, K., Kastamoulas, M., Stavroulaki, G., Giannakopoulou, A., Vessalas, G., Kitra-Roussou, V., Goussetis, E., & Peristeri, I. (2022). Allogeneic hematopoietic stem cell transplantation in infants is associated with significant morbidity and mortality. Pediatric Transplantation, 26(4), e14239. https://doi.org/10.1111/petr.14239
   PubMed Web of Science ®Google Scholar
• Otoukesh, S., Elmariah, H., Yang, D., Clark, M. C., Siraj, M., Ali, H., Mogili, K., Arslan, S., Nishihori, T., Nakamura, R., Pidala, J., Marcucci, G., Forman, S. J., Anasetti, C., Al Malki, M. M., & Bejanyan, N. (2022). Cytokine release syndrome following peripheral blood stem cell haploidentical hematopoietic cell transplantation with post-transplantation Cyclophosphamide. Transplantation and Cellular Therapy, 28(2), .e111.1–111.8. https://doi.org/10.1016/j.jtct.2021.11.012
   Google Scholar
• Pasquini, M. C., Zhang, M. -J., Medeiros, B. C., Armand, P., Hu, Z. -H., Nishihori, T., Aljurf, M. D., Akpek, G., Cahn, J. -Y., Cairo, M. S., Cerny, J., Copelan, E. A., Deol, A., Freytes, C. O., Gale, R. P., Ganguly, S., George, B., Gupta, V., Hale, G. A. … Weisdorf, D. J. (2016). Hematopoietic cell transplantation outcomes in monosomal Karyotype Myeloid Malignancies. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 22(2), 248–257. https://doi.org/10.1016/j.bbmt.2015.08.024
   PubMed Web of Science ®Google Scholar
• Penack, O., Marchetti, M., Ruutu, T., Aljurf, M., Bacigalupo, A., Bonifazi, F., Ciceri, F., Cornelissen, J., Malladi, R., Duarte, R. F., Giebel, S., Greinix, H., Holler, E., Lawitschka, A., Mielke, S., Mohty, M., Arat, M., Nagler, A., Passweg, J. … Basak, G. W. (2020). Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: Updated consensus recommendations of the European society for blood and marrow transplantation. The Lancet Haematology, 7(2), e157–167. https://doi.org/10.1016/s2352-3026(19)30256-x
   PubMed Web of Science ®Google Scholar
• Rathore, S., Varshney, A., Mohan, S., & Dahiya, P. (2022). An innovative approach of bioremediation in enzymatic degradation of xenobiotics. Biotechnology & Genetic Engineering Reviews, 38(1), 1–32. https://doi.org/10.1080/02648725.2022.2027628
   PubMed Web of Science ®Google Scholar
• Rhee, C. K., Ha, J. H., Yoon, J. H., Cho, B. S., Min, W. S., Yoon, H. K., & Lee, J. W. (2016). Risk factor and clinical outcome of bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Yonsei Medical Journal, 57(2), 365–372. https://doi.org/10.3349/ymj.2016.57.2.365
   PubMed Web of Science ®Google Scholar
• Samsonraj, R. M., Raghunath, M., Nurcombe, V., Hui, J. H., van Wijnen, A. J., & Cool, S. M. (2017). Concise review: Multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Translational Medicine, 6(12), 2173–2185. https://doi.org/10.1002/sctm.17-0129
   PubMed Web of Science ®Google Scholar
• Santo Tomas, L. H., Loberiza, F. R., Klein, J. P., Layde, P. M., Lipchik, R. J., Rizzo, J. D., Bredeson, C. N., & Horowitz, M. M. (2005). Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest, 128(1), 153–161. https://doi.org/10.1378/chest.128.1.153
   PubMed Web of Science ®Google Scholar
• Servais, S., Beguin, Y., & Baron, F. (2022). OUP accepted manuscript. Stem Cells Translational Medicine, 11(7). https://doi.org/10.1093/stcltm/szac015
   Web of Science ®Google Scholar
• Shaikh, A., Olkhanud, P. B., Gangaplara, A., Kone, A., Patel, S., Gucek, M., & Fitzhugh, C. D. (2022). Thrombospondin-1, platelet factor 4, and galectin-1 are associated with engraftment in patients with sickle cell disease who underwent haploidentical hematopoietic stem cell transplantation. Transplantation and Cellular Therapy, 28(5), 249.e1–249.e13. https://doi.org/10.1016/j.jtct.2022.01.027
   PubMedGoogle Scholar
• Sithamparanathan, S., Thirugnanasothy, L., Morley, K. E., Fisher, A. J., Lordan, J. L., Meachery, G., Parry, G., & Corris, P. A. (2016). Observational study of methotrexate in the treatment of bronchiolitis obliterans syndrome. Transplantation Proceedings, 48(10), 3387–3392. https://doi.org/10.1016/j.transproceed.2016.09.045
   PubMed Web of Science ®Google Scholar
• Thomas, L., & Hachem, R. (2016). Bronchiolitis Obliterans Syndrome (BOS) following lung transplant. American Journal of Respiratory and Critical Care Medicine, 193(11), 19–P20. https://doi.org/10.1164/rccm.19311p19
   Google Scholar
• Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8(9), 726–736. https://doi.org/10.1038/nri2395
   PubMed Web of Science ®Google Scholar
• Wang, J., Chen, Z., Sun, M., Xu, H., Gao, Y., Liu, J., & Li, M. (2020). Characterization and therapeutic applications of mesenchymal stem cells for regenerative medicine. Tissue & Cell, 64(June 2020), 101330. https://doi.org/10.1016/j.tice.2020.101330
   PubMed Web of Science ®Google Scholar
• Williams, K. M. (2017). How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Blood, 129(4), 448–455. https://doi.org/10.1182/blood-2016-08-693507
   PubMed Web of Science ®Google Scholar
• Williams, K. M., Cheng, G. -S., Pusic, I., Jagasia, M., Burns, L., Ho, V. T., Pidala, J., Palmer, J., Johnston, L., Mayer, S., Chien, J. W., Jacobsohn, D. A., Pavletic, S. Z., Martin, P. J., Storer, B. E., Inamoto, Y., Chai, X., Flowers, M. E. D., & Lee, S. J. (2016). FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 22(4), 710–716. https://doi.org/10.1016/j.bbmt.2015.10.009
   PubMed Web of Science ®Google Scholar